EN
登录

Henry Schein完成收购Shield Healthcare

Henry Schein Completes Deal for Shield Healthcare

mpo-mag 等信源发布 2024-01-09 23:53

可切换为仅中文


Henry Schein Inc. has completed its acquisition of Shield Healthcare Inc., a supplier of homecare medical products delivered directly to patients in their homes. Henry Schein announced the deal last August.

Henry Schein Inc.已完成对Shield Healthcare Inc.的收购,Shield Healthcare Inc.是一家直接向家中患者提供家庭护理医疗产品的供应商。亨利·谢恩(HenrySchein)去年8月宣布了这笔交易。

Headquartered in Valencia, Calif., Shield Healthcare reported approximately $180 million in 2022 net sales. Henry Schein expects the transaction to be neutral to 2023 non-GAAP earnings per share and accretive thereafter. Financial terms were not disclosed.

Shield Healthcare总部位于加利福尼亚州巴伦西亚,2022年净销售额约为1.8亿美元。亨利·谢恩(HenrySchein)预计,该交易在2023年非公认会计准则每股收益之前是中性的,之后会增加。财务条款未披露。

“As the health care landscape continues to shift towards home-based care, we have expanded our business delivering medical products directly to patients through our partnership with Shield Healthcare,” Henry Schein Board Chairman/CEO Stanley M. Bergman said. “Through our strategic homecare products investments, our Henry Schein Medical business is increasingly well-positioned to compete in the homecare medical supplies market.

亨利·谢恩(Henry Schein)董事会主席/首席执行官斯坦利·伯格曼(Stanley M.Bergman)表示:“随着医疗保健领域继续转向家庭护理,我们通过与Shield Healthcare的合作关系,扩大了直接向患者提供医疗产品的业务。”。“通过我们战略性的家庭护理产品投资,我们的Henry Schein医疗业务在家庭护理医疗用品市场上的竞争地位越来越高。

By combining our strong physician relationships, product distribution expertise, and corporate brand assortment, we are well positioned for growth in this market segment. We welcome our new Shield Healthcare colleagues to Team Schein, and we look forward to continued success together.” .

通过结合我们强大的医生关系、产品分销专业知识和企业品牌组合,我们在这一细分市场中处于良好的增长地位。我们欢迎新的Shield Healthcare同事加入Schein团队,我们期待着继续取得成功。”。。

Building on Henry Schein’s 2021 acquisition of Prism Medical Products LLC, Shield Healthcare will expand Henry Schein's existing medical business by delivering a diverse product range, including items such as incontinence, urology, ostomy, enteral nutrition, advanced wound care, and diabetes supplies.

Shield Healthcare将在Henry Schein 2021年收购Prism Medical Products LLC的基础上,通过提供多样化的产品系列,扩大Henry Schein现有的医疗业务,包括失禁、泌尿科、造口术、肠内营养、高级伤口护理和糖尿病用品等项目。

Additionally, it will offer continuous glucose monitoring devices directly to patients in their homes. .

此外,它将直接为家中的患者提供连续血糖监测设备。。。

The current owners of Shield Healthcare, including members of the company’s management team, will retain a minority ownership position in the company.

Shield Healthcare的现任所有者,包括公司管理团队的成员,将保留公司的少数所有权。

Henry Schein Inc. is a solutions company for healthcare professionals powered by a network of people and technology. With more than 23,000 Team Schein members worldwide, the company provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.

Henry Schein Inc.是一家为医疗保健专业人员提供解决方案的公司,由人力和技术网络提供支持。该公司在全球拥有23000多名Schein团队成员,为全球100多万客户提供了300多种有价值的解决方案,有助于提高运营成功率和临床效果。

Its business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein private-brand products in our distribution centers. A FORTUNE 500 company and a member of the S&P 500 index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories.

它的业务、临床、技术和供应链解决方案有助于办公室牙科和医生更高效地工作。这些解决方案还支持牙科实验室、政府和机构医疗诊所以及其他替代护理场所。Henry Schein通过一个集中和自动化的分销网络运营,在我们的分销中心有300000多种品牌产品和Henry Schein自有品牌产品。亨利·谢恩是《财富》500强公司和标准普尔500指数的成员,总部位于纽约州梅尔维尔,在33个国家和地区拥有业务或附属机构。

The company's sales reached $12.6 billion in 2022, and have grown at a 12.1% compound annual rate since it went public in 1995. .

2022年,该公司销售额达到126亿美元,自1995年上市以来,年复合增长率为12.1%。